1. Home
  2. IMVT vs CVI Comparison

IMVT vs CVI Comparison

Compare IMVT & CVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMVT
  • CVI
  • Stock Information
  • Founded
  • IMVT 2018
  • CVI 1906
  • Country
  • IMVT United States
  • CVI United States
  • Employees
  • IMVT N/A
  • CVI N/A
  • Industry
  • IMVT Biotechnology: Biological Products (No Diagnostic Substances)
  • CVI Integrated oil Companies
  • Sector
  • IMVT Health Care
  • CVI Energy
  • Exchange
  • IMVT Nasdaq
  • CVI Nasdaq
  • Market Cap
  • IMVT 2.8B
  • CVI 2.4B
  • IPO Year
  • IMVT N/A
  • CVI 2007
  • Fundamental
  • Price
  • IMVT $16.95
  • CVI $29.86
  • Analyst Decision
  • IMVT Buy
  • CVI Sell
  • Analyst Count
  • IMVT 10
  • CVI 5
  • Target Price
  • IMVT $40.14
  • CVI $23.00
  • AVG Volume (30 Days)
  • IMVT 1.4M
  • CVI 1.1M
  • Earning Date
  • IMVT 08-05-2025
  • CVI 07-28-2025
  • Dividend Yield
  • IMVT N/A
  • CVI 1.67%
  • EPS Growth
  • IMVT N/A
  • CVI N/A
  • EPS
  • IMVT N/A
  • CVI N/A
  • Revenue
  • IMVT N/A
  • CVI $7,393,000,000.00
  • Revenue This Year
  • IMVT N/A
  • CVI N/A
  • Revenue Next Year
  • IMVT N/A
  • CVI $7.86
  • P/E Ratio
  • IMVT N/A
  • CVI N/A
  • Revenue Growth
  • IMVT N/A
  • CVI N/A
  • 52 Week Low
  • IMVT $12.72
  • CVI $15.10
  • 52 Week High
  • IMVT $34.47
  • CVI $30.06
  • Technical
  • Relative Strength Index (RSI)
  • IMVT 60.86
  • CVI 74.20
  • Support Level
  • IMVT $15.80
  • CVI $26.69
  • Resistance Level
  • IMVT $17.06
  • CVI $27.33
  • Average True Range (ATR)
  • IMVT 0.68
  • CVI 1.12
  • MACD
  • IMVT 0.07
  • CVI 0.13
  • Stochastic Oscillator
  • IMVT 86.70
  • CVI 95.51

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.

About CVI CVR Energy Inc.

CVR Energy Inc is a holding company that engages in petroleum refining and nitrogen fertilizer manufacturing through its subsidiaries. Subsidiaries include several complex, full-coking crude oil refineries, along with a crude oil gathering system, pipelines and storage tanks, and marketing and supply. The company's refineries can process blends of a variety of crude oil ranging from heavy sour to light sweet crude oil. Crude oil for CVR's refineries is supplied through its wholly-owned gathering system and pipeline. From its refineries, CVR supplies products through tanker trucks directly to customers located in close geographic proximity and customers at throughput terminals. The company's customers include retailers, railroads, and farm cooperatives.

Share on Social Networks: